Scarica l'app Stockscreener
46.32
1.55%
-0.73
Pre-mercato:
46.75
0.43
+0.93%
Precedente Chiudi:
$47.05
Aprire:
$47.3
Volume 24 ore:
2.39M
Relative Volume:
0.78
Capitalizzazione di mercato:
$5.88B
Reddito:
$638.78M
Utile/perdita netta:
$-22.66M
Rapporto P/E:
-265.60
EPS:
-0.1744
Flusso di cassa netto:
$122.18M
1 W Prestazione:
-1.55%
1M Prestazione:
+24.68%
6M Prestazione:
+122.69%
1 anno Prestazione:
+230.86%
Intervallo 1D:
$45.56
$48.48
Intervallo di 1 settimana:
$45.01
$49.50
Portata 52W:
$11.16
$49.50
10 X Genomics Inc Stock (TXG) Company Profile
Nome
10 X Genomics Inc
Settore
Industria
Telefono
(925) 401-7300
Indirizzo
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Compare TXG vs VEEV, BTSG, HQY, TEM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TXG
10 X Genomics Inc
|
46.32 | 5.83B | 638.78M | -22.66M | 122.18M | -0.1744 |
VEEV
Veeva Systems Inc
|
207.91 | 31.59B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
69.37 | 14.13B | 13.65B | 169.86M | 412.12M | 1.0758 |
HQY
Healthequity Inc
|
104.13 | 8.28B | 1.34B | 230.70M | 440.96M | 2.6695 |
TEM
Tempus Ai Inc
|
41.55 | 7.73B | 1.36B | -302.91M | -219.93M | -1.7182 |
10 X Genomics Inc Stock (TXG) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-31 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2025-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2025-12-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2025-09-11 | Iniziato | Piper Sandler | Neutral |
| 2025-02-13 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2024-09-03 | Iniziato | Leerink Partners | Outperform |
| 2024-07-22 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-07-18 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-07-10 | Downgrade | Deutsche Bank | Buy → Hold |
| 2024-06-27 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2024-06-25 | Downgrade | Guggenheim | Buy → Neutral |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-05-01 | Downgrade | TD Cowen | Buy → Hold |
| 2023-12-14 | Iniziato | Guggenheim | Buy |
| 2023-12-13 | Iniziato | Wolfe Research | Outperform |
| 2023-12-12 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-07-05 | Ripresa | JP Morgan | Overweight |
| 2023-05-10 | Iniziato | Barclays | Overweight |
| 2023-03-31 | Iniziato | Stephens | Overweight |
| 2023-02-02 | Iniziato | UBS | Neutral |
| 2022-12-14 | Iniziato | Deutsche Bank | Buy |
| 2022-08-18 | Downgrade | Goldman | Neutral → Sell |
| 2022-07-25 | Iniziato | Canaccord Genuity | Buy |
| 2022-07-15 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-07-15 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-09-14 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-03-15 | Iniziato | William Blair | Outperform |
| 2020-12-02 | Iniziato | Goldman | Neutral |
| 2020-09-09 | Iniziato | Morgan Stanley | Overweight |
| 2020-07-10 | Iniziato | Stifel | Buy |
| 2020-03-05 | Iniziato | Guggenheim | Buy |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-10-07 | Iniziato | BofA/Merrill | Buy |
| 2019-10-07 | Iniziato | Cowen | Outperform |
| 2019-10-07 | Iniziato | JP Morgan | Overweight |
| 2019-09-24 | Iniziato | Evercore ISI | Outperform |
Mostra tutto
10 X Genomics Inc Borsa (TXG) Ultime notizie
TXG|10X Genomics Inc|Price:45.915|Chg%:-0.355 - TradingKey
10X Genomics Inc (TXG) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
TXG|10X Genomics Inc|Price:46.270|Chg%:-1.790 - TradingKey
10x Genomics, Inc. (TXG) stock price, news, quote and history - Yahoo Finance Australia
10x Genomics, Inc. (TXG) Interactive Stock Chart - Yahoo! Finance Canada
Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know - Yahoo Finance
10X Genomics2026 Funding Rounds & List of Investors - Tracxn
10X Genomics Inc (TXG) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
10x Genomics stock hits 52-week high at 46.35 USD By Investing.com - Investing.com South Africa
10x Genomics stock hits 52-week high at 46.35 USD - Investing.com UK
How 10x Genomics Inc. (TXG) Affects Rotational Strategy Timing - Stock Traders Daily
Bioinformatics Collaboration and Licensing Deals 2019-2026 | Compare Upfronts, Milestones, and Royalties for 1,230+ Deals - GlobeNewswire Inc.
10X Genomics Inc (TXG) Institutional Confidence - TradingKey
10x Genomics to Report Second Quarter 2026 Financial Results on August 6, 2026 - BioSpace
ETFs Investing in 10x Genomics Inc Class A Stocks - TradingView
10x Genomics to report Q2 2026 results on August 6 - scanx.trade
10x Genomics sets Aug. 6 webcast to discuss second-quarter results - Stock Titan
Top 3 Health Care Stocks That May Implode This Month - Benzinga
TXG Stock Rallies As Wall Street Hikes Price Targets - StocksToTrade
10x Genomics Is Maintained at Buy by Canaccord Genuity - Moomoo
4 Best Genetic Sequencing Stocks for 2026 and How to Invest - The Motley Fool
BofA Securities Adjusts 10x Genomics Price Target to $46 From $30 - Moomoo
10x Genomics, Inc. Stock 12‑Month Price Target Raised to $35.46, Implies 17% Downside - TradingView
Canaccord Genuity Maintains 10x Genomics (TXG) Buy Recommendation - MSN
10x Genomics Inc. (TXG) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Does 10x Genomics (TXG) Leaving Russell Value Indexes Reframe Its Growth Versus Profitability Story? - Yahoo Finance
TXG Stock Climbs As Wall Street Hikes Price Targets - StocksToTrade
Is 10x Genomics (TXG) Overvalued Following Its Earnings Beat? - Yahoo Finance
10x Genomics stock hits 52-week high at 40.65 USD - Investing.com
10x Genomics stock hits 52-week high at 40.65 USD By Investing.com - Investing.com India
10x Genomics, Inc. Stock 12‑Month Price Target Raised to $32.08, Implies 14% Downside - TradingView
Life Sciences Tools & Services Stocks Q1 Results: Benchmarking 10x Genomics (NASDAQ:TXG) - Yahoo Finance
10x Genomics Is Maintained at Neutral by Citigroup - Moomoo
Price to sales forward of 10x Genomics Inc Class A – SWB:1KJ - TradingView
Enterprise value to revenue forward of 10x Genomics Inc Class A – SWB:1KJ - TradingView
Enterprise value to EBIT forward of 10x Genomics Inc Class A – SWB:1KJ - TradingView
What Does 10x Genomics' (TXG) Russell Value Index Exit Reveal About Its Evolving Investor Base? - simplywall.st
1KJ Forecast — Price Target — Prediction for 2027 - TradingView
Piper Sandler raises 10X Genomics stock price target on clinical pivot - Investing.com UK
10x Genomics stock hits 52-week high at 37.58 USD - Investing.com
10x Genomics, Inc.(NasdaqGS: TXG) dropped from Russell 3000 Value Benchmark - marketscreener.com
10x Genomics Inc Class A Actuals & Estimates (FWB:1KJ) - TradingView
10x Genomics, Inc.(NasdaqGS: TXG) dropped from Russell 3000E Value Benchmark - marketscreener.com
10x Genomics Inc Class A Actuals & Estimates (DUS:1KJ) - TradingView
Stocks making big moves this week: Qualcomm, Accenture, 10x Genomics, Seagate, and Lattice Semiconductor - Yahoo Finance
Price to earnings forward of 10x Genomics, Inc. – NASDAQ:TXG - TradingView
10x Genomics Inc Class A Actuals & Estimates (MUN:1KJ) - TradingView
Enterprise value to revenue forward of 10x Genomics Inc Class A – LSE:0A88 - TradingView
10x Genomics Inc Class A Actuals & Estimates (NASDAQ:TXG) - TradingView
Enterprise value to EBIT forward of 10x Genomics Inc Class A – LSE:0A88 - TradingView
10X Genomics Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
10 X Genomics Inc Azioni (TXG) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
10 X Genomics Inc Azioni (TXG) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| SULIMAN SHEHNAAZ | Director |
Jun 16 '26 |
Sale |
32.63 |
5,723 |
186,756 |
31,722 |
1.58%
3.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):